NIPH
MRNA icon

NN Investment Partners Holdings’s Moderna MRNA Stock Holding History

NN Investment Partners Holdings’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$172K Sell
1,000
-7,833
-89% -$1.32M ﹤0.01% 731
2021
Q4 		$2.24M Sell
8,833
-10,967
-55% -$3.21M 0.01% 530
2021
Q3 		$7.62M Buy
19,800
+18,100
+1,065% +$6.68M 0.04% 332
2021
Q2 		$399K Buy
+1,700
New +$304K ﹤0.01% 723

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NN Investment Partners Holdings's MRNA Position: Q1 2022 in Review

NN Investment Partners Holdings reduced its Moderna (MRNA) stake by 89% in Q1 2022, selling an estimated $1.32M and leaving 1,000 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #731.

NN Investment Partners Holdings first reported a position in MRNA in Q2 2021 and has held it in 4 quarters since. The position peaked at $7.62M in Q3 2021. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • NN Investment Partners Holdings held 1,000 shares of Moderna worth $172K as of Q1 2022.
  • NN Investment Partners Holdings sold 7,833 Moderna shares in Q1 2022, an estimated $1.32M.
  • Moderna made up ﹤0.01% of NN Investment Partners Holdings's portfolio in Q1 2022, its #731 holding.
  • NN Investment Partners Holdings first reported a position in Moderna in Q2 2021 and has held it in 4 quarters since.
  • NN Investment Partners Holdings's Moderna position peaked at $7.62M in Q3 2021.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.